Korea United Pharm. Inc. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
136,891
155,190
162,046
176,905
197,023
211,936
Cost of Goods Sold (COGS) incl. D&A
52,957
56,941
58,069
61,402
64,601
73,181
Gross Income
83,934
98,248
103,977
115,503
132,422
138,755
SG&A Expense
68,177
74,931
79,658
87,208
99,361
99,420
EBIT
14,837
22,487
23,415
27,319
31,946
38,114
Unusual Expense
70
576
8
21
268
655
Non Operating Income/Expense
882
14
1,423
1,772
5,425
662
Interest Expense
983
1,015
703
644
441
605
Pretax Income
15,680
22,701
23,194
26,815
28,517
39,939
Income Tax
3,365
4,300
3,120
7,943
654
8,266
Equity in Affiliates
111
79
1,647
642
-
-
Consolidated Net Income
12,204
18,479
21,721
19,514
27,864
31,672
Net Income
12,212
18,375
21,725
19,514
27,864
31,672
Net Income After Extraordinaries
12,212
18,375
21,725
19,514
27,864
31,672
Net Income Available to Common
12,212
18,375
21,725
19,514
27,864
31,672
EPS (Basic)
759.80
1,163.00
1,384.00
1,277.00
1,882.00
2,139
Basic Shares Outstanding
16
16
16
15
15
15
EPS (Diluted)
750.51
1,160.15
1,384.14
1,277.48
1,881.95
2,139.20
Diluted Shares Outstanding
16
16
16
15
15
15
EBITDA
21,012
29,639
30,031
34,491
39,153
45,210
Other Operating Expense
920
831
904
976
1,115
1,222
Non-Operating Interest Income
1,014
639
845
612
576
953
Minority Interest Expense
8
104
3
-
-
-
Equity in Affiliates (Pretax)
-
-
-
-
783
1,470
About Korea United Pharm.
View Profile
